[8-K] Labcorp Holdings Inc. Reports Material Event

Rhea-AI Filing Summary

Labcorp Holdings Inc. (NYSE: LH) filed a Form 8-K under Item 7.01 (Regulation FD) to disclose that its Board of Directors has declared a cash dividend of $0.72 per common share. The dividend will be payable on September 11, 2025 to shareholders of record at the close of business on August 28, 2025. No other financial metrics, strategic initiatives, or transactional details were provided in this filing. The company furnished the related press release as Exhibit 99.1 and included standard Exhibit 104 (Inline XBRL cover data). This disclosure signals continued capital returns to shareholders and may be relevant for income-oriented investors.

Positive

• Board declared a $0.72 cash dividend payable September 11, 2025 to shareholders of record August 28, 2025, reinforcing continued cash returns.

Negative

• None.

Insights

Financial Analyst

TL;DR: Routine dividend declaration; signals ongoing capital return, impact modest.

The $0.72 per-share dividend aligns with Labcorp’s historical quarterly distribution pattern, indicating stable free cash flow and board commitment to shareholder returns. Because no change from prior payouts or special dividend premium is disclosed, the news is viewed as maintenance rather than a transformative catalyst. Income investors may welcome the confirmation of schedule and amount, but growth-oriented holders will find limited incremental insight.

Income Portfolio Manager

TL;DR: Dividend confirmation supports yield stability; neutral on valuation.

A declared payout of $0.72 payable 9/11/25 provides visibility for dividend capture strategies and ex-dividend planning. However, without comparative yield data or guidance revisions, the announcement does not materially shift total-return expectations. Overall market impact is likely muted, keeping the disclosure in the neutral category.

0000920148false00009201482025-07-092025-07-09

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C.  20549

FORM 8-K

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

July 9, 2025

(Date of earliest event reported)

LABCORP HOLDINGS INC.

(Exact Name of Registrant as Specified in its Charter)

Delaware

1-11353

99-2588107

(State or other jurisdiction of Incorporation)

(Commission File Number)

(I.R.S. Employer Identification No.)

358 South Main Street

Burlington

,

North Carolina

27215

(Address of principal executive offices)

(Zip Code)

(Registrant’s telephone number including area code) 336-229-1127

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐			Written communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐			Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐			Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐			Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class

Trading Symbol

Name of exchange on which registered

Common Stock, $0.10 par value

LH

New York Stock Exchange

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 7.01 Regulation FD Disclosure

Labcorp Holdings Inc. (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced on July 10, 2025 that its Board of Directors has declared a cash dividend in the amount of $0.72 per share of common stock. The dividend will be payable on September 11, 2025, to stockholders of record as of the close of business on August 28, 2025. A copy of the press release is furnished as Exhibit 99.1 hereto and incorporated by reference herein.

Item 9.01			Financial Statements and Exhibits.
Exhibit			Exhibit Name
Exhibit 99.1			Press release dated July 10, 2025 issued by Labcorp Holdings Inc.
Exhibit 104			Cover Page Interactive Data File (embedded within the Inline XBRL document)

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

LABCORP HOLDINGS INC.

Registrant

Date: July 10, 2025			By:			/s/ SANDRA D. VAN DER VAART
						Sandra D. van der Vaart
						Executive Vice President, Chief Legal Officer and Corporate Secretary

FAQ

What dividend did Labcorp (LH) announce in its July 2025 8-K?

Labcorp declared a $0.72 per-share cash dividend.

When is the record date for Labcorp’s $0.72 dividend?

The record date is August 28, 2025.

When will Labcorp pay the announced dividend?

Payment is scheduled for September 11, 2025.

Which exhibit contains the official dividend press release?

The press release is filed as Exhibit 99.1.

Does the 8-K include any earnings or transaction data?

No, the filing solely covers the dividend announcement and related exhibits.